Why Ocular Therapeutix Was Bumping Higher This Week
The market was seeing Ocular Therapeutix (NASDAQ: OCUL) very positively this week, and that sunny view pushed the company's stock higher.
As of Friday morning before market open, the eye care specialist's shares were up by nearly 5% in price week to date, according to data compiled by S&P Global Market Intelligence. A key catalyst for this was an analyst's bullish initiation of coverage on the biotech's stock.
Early Tuesday morning, Needham's Serge Belanger formally became an Ocular analyst. He inaugurated his run by tagging the company's stock as a buy at a price target of $15 per share. That's nearly double the stock's current level.
Source Fool.com
Ocular Therapeutix Inc. Stock
€8.70
-3.410%
With 25 Buy predictions and 2 Sell predictions Ocular Therapeutix Inc. is one of the favorites of our community.
With a target price of 17 € there is a hugely positive potential of 95.4% for Ocular Therapeutix Inc. compared to the current price of 8.7 €.
